Literature DB >> 6878247

Association between rising haemoglobin concentration and renal cyst formation in patients on long term regular haemodialysis treatment.

H J Goldsmith, R Ahmad, N Raichura, S M Lal, C A McConnell, D A Gould, O H Gyde, J Green.   

Abstract

Seventeen of 20 (85%) patients on RDT for six to 13 years were found to have acquired renal cysts. There was a significant positive association between Hb and duration of RDT. The extent of cyst was positively and significantly correlated with the latest Hb and years on dialysis. There was also a significant positive correlation between size and years on dialysis only approached statistical significance. There was no correlation between kidney size and latest Hb. Complications in patients with acquired renal cysts appear to resemble those of familial polycystic disease with the added risk of neoplasia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6878247

Source DB:  PubMed          Journal:  Proc Eur Dial Transplant Assoc        ISSN: 0071-2736


  4 in total

1.  Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients.

Authors:  David A Goodkin; Douglas S Fuller; Bruce M Robinson; Christian Combe; Richard Fluck; David Mendelssohn; Tadao Akizawa; Ronald L Pisoni; Friedrich K Port
Journal:  J Am Soc Nephrol       Date:  2010-12-16       Impact factor: 10.121

2.  Clinical importance of acquired cystic disease of the kidney in patients undergoing dialysis.

Authors:  P J Ratcliffe; M S Dunnill; D O Oliver
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-17

3.  Acquired cystic kidney disease in children undergoing long-term dialysis.

Authors:  H E Leichter; R Dietrich; I B Salusky; J Foley; A H Cohen; H Kangarloo; R N Fine
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714

Review 4.  Non-Hodgkin's lymphoma of the thyroid and adrenal glands.

Authors:  D H Lee; J H Park; J J Lee; I J Chung; D J Chung; M Y Chung; T H Lee
Journal:  Korean J Intern Med       Date:  2000-01       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.